UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000007180
Receipt No. R000007139
Scientific Title A phase II neoadjuvant trial of sequential tri-weekly nanoparticle albumin-bound paclitaxel (Abraxane)/cyclophosphamide, with trastuzumab in HER2-positive patients, followed by 5-fluorouracil/epirubicine/cyclophosphamide (FEC) in operable breast cancer
Date of disclosure of the study information 2012/02/01
Last modified on 2019/08/03 09:07:56

No. Disposal Last modified on Item of update
1 Insert 2012/01/31 15:58:30
2 Update 2014/07/31 12:36:38 Recruitment status
3 Update 2015/08/18 08:12:26 Recruitment status
4 Update 2015/08/18 08:14:00 Publication of results
URL related to results and publications
5 Update 2015/08/18 08:15:00 Key inclusion criteria
6 Update 2015/08/18 08:20:08 Email
Email
7 Update 2019/08/03 08:58:20 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of primary sponsor
Organization
Organization
Organization
Address
Address
Tel
Email
8 Update 2019/08/03 09:03:56 Number of participants that the trial has enrolled
Results
Results
Results date posted
9 Update 2019/08/03 09:07:36 Date of IRB
Last follow-up date
10 Update 2019/08/03 09:07:56 Recruitment status


Contact us.